These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 35428613)

  • 1. Quality of life, healthcare use and costs in 'at-risk' children after early antibiotic treatment versus placebo for influenza-like illness: within-trial descriptive economic analyses of the ARCHIE randomised controlled trial.
    Rombach I; Wang K; Tonner S; Grabey J; Harnden A; Wolstenholme J; ;
    BMJ Open; 2022 Apr; 12(4):e049373. PubMed ID: 35428613
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early use of Antibiotics for at Risk CHildren with InfluEnza (ARCHIE): protocol for a double-blind, randomised, placebo-controlled trial.
    Wang K; Carver T; Tonner S; Semple MG; Hay AD; Moore M; Little P; Butler C; Farmer A; Perera R; Yu LM; Mallett S; Wolstenholme J; Harnden A
    BMJ Open; 2018 May; 8(5):e021144. PubMed ID: 29769256
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The early use of Antibiotics for at Risk CHildren with InfluEnza-like illness (ARCHIE): a double-blind randomised placebo-controlled trial.
    Wang K; Semple MG; Moore M; Hay AD; Tonner S; Galal U; Grabey J; Carver T; Perera R; Yu LM; Mollison J; Little P; Farmer A; Butler CC; Harnden A
    Eur Respir J; 2021 Oct; 58(4):. PubMed ID: 33737410
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Amoxicillin duration and dose for community-acquired pneumonia in children: the CAP-IT factorial non-inferiority RCT.
    Barratt S; Bielicki JA; Dunn D; Faust SN; Finn A; Harper L; Jackson P; Lyttle MD; Powell CV; Rogers L; Roland D; Stöhr W; Sturgeon K; Vitale E; Wan M; Gibb DM; Sharland M
    Health Technol Assess; 2021 Nov; 25(60):1-72. PubMed ID: 34738518
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Daily low-dose prednisolone to prevent relapse of steroid-sensitive nephrotic syndrome in children with an upper respiratory tract infection: PREDNOS2 RCT.
    Christian MT; Webb NJ; Woolley RL; Afentou N; Mehta S; Frew E; Brettell EA; Khan AR; Milford DV; Bockenhauer D; Saleem MA; Hall AS; Koziell A; Maxwell H; Hegde S; Finlay ER; Gilbert RD; Jones C; McKeever K; Cook W; Ives N
    Health Technol Assess; 2022 Jan; 26(3):1-94. PubMed ID: 35060851
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intravenous co-amoxiclav to prevent infection after operative vaginal delivery: the ANODE RCT.
    Knight M; Chiocchia V; Partlett C; Rivero-Arias O; Hua X; Bowler U; Gray J; Gray S; Hinshaw K; Khunda A; Moore P; Mottram L; Owino N; Pasupathy D; Sanders J; Sultan AH; Thakar R; Tuffnell D; Linsell L; Juszczak E
    Health Technol Assess; 2019 Oct; 23(54):1-54. PubMed ID: 31590702
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Economic evaluation of the OSAC randomised controlled trial: oral corticosteroids for non-asthmatic adults with acute lower respiratory tract infection in primary care.
    Moure-Fernandez A; Hollinghurst S; Carroll FE; Downing H; Young G; Brookes S; May M; El-Gohary M; Harnden A; Kendrick D; Lafond N; Little P; Moore M; Orton E; Thompson M; Timmins D; Wang K; Hay AD
    BMJ Open; 2020 Feb; 10(2):e033567. PubMed ID: 32075830
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immediate oral versus immediate topical versus delayed oral antibiotics for children with acute otitis media with discharge: the REST three-arm non-inferiority electronic platform-supported RCT.
    Hay AD; Moore MV; Taylor J; Turner N; Noble S; Cabral C; Horwood J; Prasad V; Curtis K; Delaney B; Damoiseaux R; Domínguez J; Tapuria A; Harris S; Little P; Lovering A; Morris R; Rowley K; Sadoo A; Schilder A; Venekamp R; Wilkes S; Curcin V
    Health Technol Assess; 2021 Nov; 25(67):1-76. PubMed ID: 34816795
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MAGNEsium Trial In Children (MAGNETIC): a randomised, placebo-controlled trial and economic evaluation of nebulised magnesium sulphate in acute severe asthma in children.
    Powell CV; Kolamunnage-Dona R; Lowe J; Boland A; Petrou S; Doull I; Hood K; Williamson PR;
    Health Technol Assess; 2013 Oct; 17(45):v-vi, 1-216. PubMed ID: 24144222
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anaesthetic-analgesic ear drops to reduce antibiotic consumption in children with acute otitis media: the CEDAR RCT.
    Hay AD; Downing H; Francis NA; Young GJ; Clement C; Harris SD; Ahern A; Schofield B; Thomas TE; Horwood J; Blair PS; Hollingworth W; Wilson V; Metcalfe C; Stoddart P; Nunez D; Lyttle MD; Little P; Moore MV
    Health Technol Assess; 2019 Jul; 23(34):1-48. PubMed ID: 31304912
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Group cognitive-behavioural programme to reduce the impact of rheumatoid arthritis fatigue: the RAFT RCT with economic and qualitative evaluations.
    Hewlett S; Almeida C; Ambler N; Blair PS; Choy E; Dures E; Hammond A; Hollingworth W; Kadir B; Kirwan J; Plummer Z; Rooke C; Thorn J; Turner N; Pollock J
    Health Technol Assess; 2019 Oct; 23(57):1-130. PubMed ID: 31601357
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of oral amoxicillin-clavulanate or azithromycin for non-severe respiratory exacerbations in children with bronchiectasis (BEST-1): a multicentre, three-arm, double-blind, randomised placebo-controlled trial.
    Goyal V; Grimwood K; Ware RS; Byrnes CA; Morris PS; Masters IB; McCallum GB; Binks MJ; Smith-Vaughan H; O'Grady KF; Champion A; Buntain HM; Schultz A; Chatfield M; Torzillo PJ; Chang AB
    Lancet Respir Med; 2019 Sep; 7(9):791-801. PubMed ID: 31427252
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structured, intensive education maximising engagement, motivation and long-term change for children and young people with diabetes: a cluster randomised controlled trial with integral process and economic evaluation - the CASCADE study.
    Christie D; Thompson R; Sawtell M; Allen E; Cairns J; Smith F; Jamieson E; Hargreaves K; Ingold A; Brooks L; Wiggins M; Oliver S; Jones R; Elbourne D; Santos A; Wong IC; O'Neill S; Strange V; Hindmarsh P; Annan F; Viner R
    Health Technol Assess; 2014 Mar; 18(20):1-202. PubMed ID: 24690402
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An intervention to improve the quality of life in children of parents with serious mental illness: the Young SMILES feasibility RCT.
    Abel KM; Bee P; Gega L; Gellatly J; Kolade A; Hunter D; Callender C; Carter LA; Meacock R; Bower P; Stanley N; Calam R; Wolpert M; Stewart P; Emsley R; Holt K; Linklater H; Douglas S; Stokes-Crossley B; Green J
    Health Technol Assess; 2020 Nov; 24(59):1-136. PubMed ID: 33196410
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Estimates and determinants of economic impacts from influenza-like illnesses caused by respiratory viruses in Australian children attending childcare: a cohort study.
    Yin JK; Salkeld G; Lambert SB; Dierig A; Heron L; Leask J; Yui Kwan Chow M; Booy R
    Influenza Other Respir Viruses; 2013 Nov; 7(6):1103-12. PubMed ID: 23829670
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A clinical and economic evaluation of Control of Hyperglycaemia in Paediatric intensive care (CHiP): a randomised controlled trial.
    Macrae D; Grieve R; Allen E; Sadique Z; Betts H; Morris K; Pappachan VJ; Parslow R; Tasker RC; Baines P; Broadhead M; Duthie ML; Fortune PM; Inwald D; McMaster P; Peters MJ; Schindler M; Guerriero C; Piercy D; Slavik Z; Snowdon C; Van Dyck L; Elbourne D
    Health Technol Assess; 2014 Apr; 18(26):1-210. PubMed ID: 24780450
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Methenamine hippurate compared with antibiotic prophylaxis to prevent recurrent urinary tract infections in women: the ALTAR non-inferiority RCT.
    Harding C; Chadwick T; Homer T; Lecouturier J; Mossop H; Carnell S; King W; Abouhajar A; Vale L; Watson G; Forbes R; Currer S; Pickard R; Eardley I; Pearce I; Thiruchelvam N; Guerrero K; Walton K; Hussain Z; Lazarowicz H; Ali A
    Health Technol Assess; 2022 May; 26(23):1-172. PubMed ID: 35535708
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cost-benefit evaluation of routine influenza immunisation in people 65-74 years of age.
    Allsup S; Gosney M; Haycox A; Regan M
    Health Technol Assess; 2003; 7(24):iii-x, 1-65. PubMed ID: 14499051
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy, safety and tolerability of 3 day azithromycin versus 10 day co-amoxiclav in the treatment of children with acute lower respiratory tract infections.
    Ferwerda A; Moll HA; Hop WC; Kouwenberg JM; Tjon Pian Gi CV; Robben SG; de Groot R
    J Antimicrob Chemother; 2001 Apr; 47(4):441-6. PubMed ID: 11266417
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.